Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua P Lewis

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Pharmacogenomics and Personalized Medicine|April 22, 2015
Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomicsAmber L Beitelshees, Deepak Voora, Joshua P Lewis
Expert Opinion on Drug Metabolism & Toxicology|July 16, 2015
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19Yao Yang, Joshua P Lewis, Jean-Sébastien Hulot, et al.
American Journal of Physiology. Cell Physiology|March 24, 2021
Biomimetic microsystems for cardiovascular studiesShelby C Inbody, Bridgett E Sinquefield, Joshua P Lewis, et al.
Current Pharmaceutical Design|August 19, 2017
Genetic Variants of PEAR1 are Associated with Platelet Function and Antiplatelet Drug Efficacy: A Systematic Review and Meta-AnalysisQian Xiang, Shuang Zhou, Joshua P Lewis, et al.
Diabetes|April 30, 2008
Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studiesJoshua P Lewis, Nicholette D Palmer, Pamela J Hicks, et al.
Genomics|July 24, 2010
Analysis of candidate genes on chromosome 20q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European AmericansJoshua P Lewis, Nicholette D Palmer, Jennifer B Ellington, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 3, 2015
Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adultsXi-Ling Jiang, Snehal Samant, Joshua P Lewis, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|August 18, 2017
A comparative study of different methods for automatic identification of clopidogrel-induced bleedings in electronic health recordsHee-Jin Lee, Min Jiang, Yonghui Wu, et al.
Journal of the American Heart Association|November 2, 2016
Clopidogrel Improves Skin Microcirculatory Endothelial Function in Persons With Heightened Platelet AggregationShabnam Salimi, Joshua P Lewis, Laura M Yerges-Armstrong, et al.
Clinical and Translational Science|November 22, 2024
Randomized evaluation of the loss-of-function carboxylesterase 1 (CES1) G143E variant on clopidogrel and ticagrelor pharmacodynamicsJoshua P Lewis, Kathleen A Ryan, Elizabeth A Streeten, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Pharmacogenomics and Personalized Medicine|April 22, 2015
Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomicsAmber L Beitelshees, Deepak Voora, Joshua P Lewis
Expert Opinion on Drug Metabolism & Toxicology|July 16, 2015
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19Yao Yang, Joshua P Lewis, Jean-Sébastien Hulot, et al.
American Journal of Physiology. Cell Physiology|March 24, 2021
Biomimetic microsystems for cardiovascular studiesShelby C Inbody, Bridgett E Sinquefield, Joshua P Lewis, et al.
Current Pharmaceutical Design|August 19, 2017
Genetic Variants of PEAR1 are Associated with Platelet Function and Antiplatelet Drug Efficacy: A Systematic Review and Meta-AnalysisQian Xiang, Shuang Zhou, Joshua P Lewis, et al.
Diabetes|April 30, 2008
Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studiesJoshua P Lewis, Nicholette D Palmer, Pamela J Hicks, et al.
Genomics|July 24, 2010
Analysis of candidate genes on chromosome 20q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European AmericansJoshua P Lewis, Nicholette D Palmer, Jennifer B Ellington, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 3, 2015
Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adultsXi-Ling Jiang, Snehal Samant, Joshua P Lewis, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|August 18, 2017
A comparative study of different methods for automatic identification of clopidogrel-induced bleedings in electronic health recordsHee-Jin Lee, Min Jiang, Yonghui Wu, et al.
Journal of the American Heart Association|November 2, 2016
Clopidogrel Improves Skin Microcirculatory Endothelial Function in Persons With Heightened Platelet AggregationShabnam Salimi, Joshua P Lewis, Laura M Yerges-Armstrong, et al.
Clinical and Translational Science|November 22, 2024
Randomized evaluation of the loss-of-function carboxylesterase 1 (CES1) G143E variant on clopidogrel and ticagrelor pharmacodynamicsJoshua P Lewis, Kathleen A Ryan, Elizabeth A Streeten, et al.
Pageof 6